Mark Wasner

576 total citations
8 papers, 485 citations indexed

About

Mark Wasner is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Mark Wasner has authored 8 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 1 paper in Cell Biology. Recurrent topics in Mark Wasner's work include Cancer-related Molecular Pathways (6 papers), Genomics and Chromatin Dynamics (4 papers) and Ubiquitin and proteasome pathways (3 papers). Mark Wasner is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Genomics and Chromatin Dynamics (4 papers) and Ubiquitin and proteasome pathways (3 papers). Mark Wasner collaborates with scholars based in Germany and Italy. Mark Wasner's co-authors include Kurt Engeland, Ulrike Haugwitz, Joachim Mössner, Roberto Mantovani, Katrin Tschöp, Wibke Reinhard, Antonella Ronchi, Fabrizio Bolognese, Isabella Manni and Aymone Gurtner and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Oncogene.

In The Last Decade

Mark Wasner

8 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Wasner Germany	8	390	213	81	65	44	8	485
Wilson W. Marhin Canada	7	414 1.1×	252 1.2×	66 0.8×	67 1.0×	37 0.8×	7	544
Akihisa Fukumoto Japan	7	298 0.8×	159 0.7×	124 1.5×	30 0.5×	49 1.1×	13	399
De-Chang Wu China	9	455 1.2×	170 0.8×	103 1.3×	49 0.8×	40 0.9×	21	568
Yulei Du China	11	273 0.7×	111 0.5×	107 1.3×	56 0.9×	29 0.7×	16	396
Dragana Kopanja United States	16	624 1.6×	230 1.1×	136 1.7×	66 1.0×	32 0.7×	20	739
Feng Dong United States	8	279 0.7×	277 1.3×	58 0.7×	65 1.0×	23 0.5×	16	381
Alessandra Ianari United States	7	517 1.3×	299 1.4×	91 1.1×	64 1.0×	23 0.5×	9	592
T Koh Japan	7	263 0.7×	165 0.8×	61 0.8×	79 1.2×	77 1.8×	10	541
Kinnimulki Vijayachandra United States	10	369 0.9×	95 0.4×	52 0.6×	35 0.5×	48 1.1×	10	492
Yvette Garbe Germany	5	155 0.4×	252 1.2×	107 1.3×	31 0.5×	52 1.2×	7	380

Countries citing papers authored by Mark Wasner

Since Specialization

Citations

This map shows the geographic impact of Mark Wasner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wasner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wasner more than expected).

Fields of papers citing papers by Mark Wasner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Wasner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wasner. The network helps show where Mark Wasner may publish in the future.

Co-authorship network of co-authors of Mark Wasner

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Wasner. A scholar is included among the top collaborators of Mark Wasner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Wasner. Mark Wasner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Rother, Karen, Ulrike Haugwitz, Katrin Tschöp, et al.. (2004). Identification of Tcf-4 as a transcriptional target of p53 signalling. Oncogene. 23(19). 3376–3384. 53 indexed citations

2.

Wasner, Mark, Ulrike Haugwitz, Wibke Reinhard, et al.. (2003). Three CCAAT-boxes and a single cell cycle genes homology region (CHR) are the major regulating sites for transcription from the human cyclin B2 promoter. Gene. 312. 225–237. 48 indexed citations

3.

Salsi, Valentina, Giuseppina Caretti, Mark Wasner, et al.. (2003). Interactions between p300 and Multiple NF-Y Trimers Govern Cyclin B2 Promoter Function. Journal of Biological Chemistry. 278(9). 6642–6650. 64 indexed citations

4.

Wasner, Mark, Katrin Tschöp, Ulrike Haugwitz, et al.. (2003). Cyclin B1 transcription is enhanced by the p300 coactivator and regulated during the cell cycle by a CHR‐dependent repression mechanism. FEBS Letters. 536(1-3). 66–70. 56 indexed citations

5.

Thiele, Andrea, Mark Wasner, Claudia Müller, Kurt Engeland, & Sunna Hauschildt. (2001). Regulation and Possible Function of β-Catenin in Human Monocytes. The Journal of Immunology. 167(12). 6786–6793. 33 indexed citations

6.

Haugwitz, Ulrike, et al.. (2001). Expression of the Cell Cycle Phosphatase cdc25C Is Down-Regulated by the Tumor Suppressor Protein p53 but Not by p73. Biochemical and Biophysical Research Communications. 284(3). 743–750. 48 indexed citations

7.

Tannapfel, Andrea, Alexander Katalinic, Dirk Uhlmann, et al.. (2000). Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma. International Journal of Cancer. 89(4). 350–355. 76 indexed citations

8.

Bolognese, Fabrizio, Mark Wasner, Aymone Gurtner, et al.. (1999). The cyclin B2 promoter depends on NF-Y, a trimer whose CCAAT-binding activity is cell-cycle regulated. Oncogene. 18(10). 1845–1853. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact